Evoke Pharma Inc Annual Interest Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Evoke Pharma Inc quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
  • Evoke Pharma Inc Interest Expense for the quarter ending June 30, 2024 was $125K, a 0% decline year-over-year.
  • Evoke Pharma Inc Interest Expense for the twelve months ending June 30, 2024 was $501K, a 0.27% increase year-over-year.
  • Evoke Pharma Inc annual Interest Expense for 2023 was $500K, unchanged from 2022.
  • Evoke Pharma Inc annual Interest Expense for 2022 was $500K, a 0.01% decline from 2021.
  • Evoke Pharma Inc annual Interest Expense for 2021 was $500K, a 343% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $500K $0 0% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 $500K -$50 -0.01% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 $500K +$387K +343% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $113K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2014 $108K -$52.1K -32.6% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-04
2013 $160K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.